Maplight Therapeutics, Inc. · NASDAQ:MPLT
Gillis Jonathan sold 10,167 Maplight Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Gillis Jonathan (CAO and Interim CFO) sold 10,167 Maplight Therapeutics, Inc. shares at US$8.08 for US$82,149, leaving 142,315 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 10,167 shares
- Price
- US$8.08
- Value
- US$82,149
- Holding after
- 142,315 shares
- Trading plan
- No
- Role
- CAO and Interim CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Voting Common Stock | Sale | 10,167 | US$8.08 | 142,315 | Direct |
Source
Download original · View original at SEC
Related
- Maplight Therapeutics, Inc.
- Gillis Jonathan
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Gillis Jonathan · Aug 19, 2026
- Form 4 · Gillis Jonathan · Jul 20, 2026
- Form 4 · Gillis Jonathan · Apr 29, 2026
- Form 4 · Gillis Jonathan · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026